tradingkey.logo


Select Medical Holdings Corp

SEM
14.770USD
-0.070-0.47%
āļ›āļīāļ” 12/26, 16:00ETāļĢāļēāļ„āļēāļĨāđˆāļēāļŠāđ‰āļē 15 āļ™āļēāļ—āļĩ
1.83BāļĄāļđāļĨāļ„āđˆāļēāļ•āļĨāļēāļ”
16.90P/E TTM


āļĢāļēāļĒāļĨāļ°āđ€āļ­āļĩāļĒāļ”āđ€āļžāļīāđˆāļĄāđ€āļ•āļīāļĄāļ‚āļ­āļ‡ Select Medical Holdings Corp āļšāļĢāļīāļĐāļąāļ—

Select Medical Holdings Corporation operates critical illness recovery hospitals, rehabilitation hospitals, and outpatient rehabilitation clinics in the United States. Its segments include Critical Illness Recovery Hospital, Rehabilitation Hospital, and Outpatient Rehabilitation. Critical Illness Recovery Hospital segment consists of hospitals designed to serve the needs of patients recovering from critical illnesses, often with complex medical needs. It operates the majority of its critical illness recovery hospitals as a hospital within a hospital (an HIH). Rehabilitation Hospital segment serves patients that require intensive physical rehabilitation care. Outpatient Rehabilitation segment consists of clinics that provide physical, occupational, and speech rehabilitation services. It operates around 104 critical illness recovery hospitals in 29 states, 35 rehabilitation hospitals in 14 states, and 1,914 outpatient rehabilitation clinics in 39 states and the District of Columbia.

āļ‚āđ‰āļ­āļĄāļđāļĨ Select Medical Holdings Corp


āļŠāļąāļāļĨāļąāļāļĐāļ“āđŒāļĒāđˆāļ­āļ‚āļ­āļ‡āļŦāļļāđ‰āļ™SEM
āļŠāļ·āđˆāļ­āļšāļĢāļīāļĐāļąāļ—Select Medical Holdings Corp
āļ§āļąāļ™āļ—āļĩāđˆāđ€āļŠāļ™āļ­āļ‚āļēāļĒāļ„āļĢāļąāđ‰āļ‡āđāļĢāļSep 25, 2009
āļ‹āļĩāļ­āļĩāđ‚āļ­Mullin (Thomas P)
āļˆāļģāļ™āļ§āļ™āļžāļ™āļąāļāļ‡āļēāļ™30000
āļ›āļĢāļ°āđ€āļ āļ—āļāļēāļĢāļĢāļąāļāļĐāļēāļ„āļ§āļēāļĄāļ›āļĨāļ­āļ”āļ āļąāļĒOrdinary Share
āļŠāļīāđ‰āļ™āļ›āļĩāļ‡āļšāļ›āļĢāļ°āļĄāļēāļ“Sep 25
āļ—āļĩāđˆāļ­āļĒāļđāđˆC/O Select Medical Corp
āđ€āļĄāļ·āļ­āļ‡MECHANICSBURG
āļ•āļĨāļēāļ”āļŦāļĨāļąāļāļ—āļĢāļąāļžāļĒāđŒNASDAQ OMX NASDAQ Basic NYSE
āļ›āļĢāļ°āđ€āļ—āļĻUnited States of America
āļĢāļŦāļąāļŠāđ„āļ›āļĢāļĐāļ“āļĩāļĒāđŒ17055
āđ‚āļ—āļĢāļĻāļąāļžāļ—āđŒ17179721100
āđ€āļ§āđ‡āļšāđ„āļ‹āļ•āđŒhttps://www.selectmedical.com/
āļŠāļąāļāļĨāļąāļāļĐāļ“āđŒāļĒāđˆāļ­āļ‚āļ­āļ‡āļŦāļļāđ‰āļ™SEM
āļ§āļąāļ™āļ—āļĩāđˆāđ€āļŠāļ™āļ­āļ‚āļēāļĒāļ„āļĢāļąāđ‰āļ‡āđāļĢāļSep 25, 2009
āļ‹āļĩāļ­āļĩāđ‚āļ­Mullin (Thomas P)

āļœāļđāđ‰āļšāļĢāļīāļŦāļēāļĢāļšāļĢāļīāļĐāļąāļ—āļ‚āļ­āļ‡ Select Medical Holdings Corp


āļŠāļ·āđˆāļ­
āļŠāļ·āđˆāļ­/āļ•āļģāđāļŦāļ™āđˆāļ‡
āļ•āļģāđāļŦāļ™āđˆāļ‡
āļāļēāļĢāļ–āļ·āļ­āļŦāļļāđ‰āļ™
āđ€āļ›āļĨāļĩāđˆāļĒāļ™
Mr. Robert A. Ortenzio
Mr. Robert A. Ortenzio
Executive Chairman of the Board, Co-Founder
Executive Chairman of the Board, Co-Founder
9.93M
+7.96%
Mr. Martin F. Jackson
Mr. Martin F. Jackson
Senior Executive Vice President of Strategic Finance and Operations
Senior Executive Vice President of Strategic Finance and Operations
1.38M
-0.76%
Mr. David S. Chernow
Mr. David S. Chernow
Vice Chairman of the Board
Vice Chairman of the Board
892.83K
-5.21%
Mr. Russell L. Carson
Mr. Russell L. Carson
Lead Independent Director
Lead Independent Director
610.03K
+2.35%
Mr. Thomas P. (Tom) Mullin
Mr. Thomas P. (Tom) Mullin
Chief Executive Officer
Chief Executive Officer
391.71K
-5.33%
Mr. Brian R. Rusignuolo
Mr. Brian R. Rusignuolo
Executive Vice President, Chief Information Officer
Executive Vice President, Chief Information Officer
361.37K
-3.90%
Mr. Michael F. Malatesta
Mr. Michael F. Malatesta
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
238.06K
-3.00%
Mr. Thomas A. (Tom) Scully, J.D.
Mr. Thomas A. (Tom) Scully, J.D.
Independent Director
Independent Director
89.39K
+12.60%
Dr. Parvinderjit Singh Khanuja
Dr. Parvinderjit Singh Khanuja
Independent Director
Independent Director
79.12K
+21.56%
Ms. Katherine R. Davisson
Ms. Katherine R. Davisson
Independent Director
Independent Director
60.03K
+30.51%
āļ”āļđāđ€āļžāļīāđˆāļĄāđ€āļ•āļīāļĄ
āļŠāļ·āđˆāļ­
āļŠāļ·āđˆāļ­/āļ•āļģāđāļŦāļ™āđˆāļ‡
āļ•āļģāđāļŦāļ™āđˆāļ‡
āļāļēāļĢāļ–āļ·āļ­āļŦāļļāđ‰āļ™
āđ€āļ›āļĨāļĩāđˆāļĒāļ™
Mr. Robert A. Ortenzio
Mr. Robert A. Ortenzio
Executive Chairman of the Board, Co-Founder
Executive Chairman of the Board, Co-Founder
9.93M
+7.96%
Mr. Martin F. Jackson
Mr. Martin F. Jackson
Senior Executive Vice President of Strategic Finance and Operations
Senior Executive Vice President of Strategic Finance and Operations
1.38M
-0.76%
Mr. David S. Chernow
Mr. David S. Chernow
Vice Chairman of the Board
Vice Chairman of the Board
892.83K
-5.21%
Mr. Russell L. Carson
Mr. Russell L. Carson
Lead Independent Director
Lead Independent Director
610.03K
+2.35%
Mr. Thomas P. (Tom) Mullin
Mr. Thomas P. (Tom) Mullin
Chief Executive Officer
Chief Executive Officer
391.71K
-5.33%
Mr. Brian R. Rusignuolo
Mr. Brian R. Rusignuolo
Executive Vice President, Chief Information Officer
Executive Vice President, Chief Information Officer
361.37K
-3.90%

āļŠāļąāļ”āļŠāđˆāļ§āļ™āļ‚āļ­āļ‡āļĢāļēāļĒāđ„āļ”āđ‰

āļŠāļāļļāļĨāđ€āļ‡āļīāļ™: USDāļ­āļąāļ›āđ€āļ”āļ•āđ€āļĄāļ·āđˆāļ­: āļ§āļąāļ™āļˆāļąāļ™āļ—āļĢāđŒāļ—āļĩāđˆ 6 āļ•.āļ„.
āļŠāļāļļāļĨāđ€āļ‡āļīāļ™: USDāļ­āļąāļ›āđ€āļ”āļ•āđ€āļĄāļ·āđˆāļ­: āļ§āļąāļ™āļˆāļąāļ™āļ—āļĢāđŒāļ—āļĩāđˆ 6 āļ•.āļ„.
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
āļ•āļēāļĄāļ˜āļļāļĢāļāļīāļˆUSD
āļŠāļ·āđˆāļ­
āļĢāļēāļĒāđ„āļ”āđ‰
āļŠāļąāļ”āļŠāđˆāļ§āļ™
Non-Medicar
826.30M
61.68%
Medicare
381.56M
28.48%
Other
97.08M
7.25%
Other revenues
34.64M
2.59%
āļ‚āđ‰āļ­āļĄāļđāļĨāļ—āļĩāđˆāđ€āļāļĩāđˆāļĒāļ§āļ‚āđ‰āļ­āļ‡āļĒāļąāļ‡āđ„āļĄāđˆāđ„āļ”āđ‰āļĢāļąāļšāļāļēāļĢāđ€āļ›āļīāļ”āđ€āļœāļĒāļˆāļēāļāļ—āļēāļ‡āļšāļĢāļīāļĐāļąāļ—
āļ•āļēāļĄāļ˜āļļāļĢāļāļīāļˆ
āļ•āļēāļĄāļ āļđāļĄāļīāļ āļēāļ„
āļ•āļēāļĄāļ˜āļļāļĢāļāļīāļˆUSD
āļŠāļ·āđˆāļ­
āļĢāļēāļĒāđ„āļ”āđ‰
āļŠāļąāļ”āļŠāđˆāļ§āļ™
Non-Medicar
826.30M
61.68%
Medicare
381.56M
28.48%
Other
97.08M
7.25%
Other revenues
34.64M
2.59%

āļŠāļ–āļīāļ•āļīāļāļēāļĢāļ–āļ·āļ­āļŦāļļāđ‰āļ™

āļ­āļąāļ›āđ€āļ”āļ•āđ€āļĄāļ·āđˆāļ­: āļ§āļąāļ™āļ­āļēāļ—āļīāļ•āļĒāđŒāļ—āļĩāđˆ 16 āļž.āļĒ.
āļ­āļąāļ›āđ€āļ”āļ•āđ€āļĄāļ·āđˆāļ­: āļ§āļąāļ™āļ­āļēāļ—āļīāļ•āļĒāđŒāļ—āļĩāđˆ 16 āļž.āļĒ.
āļœāļđāđ‰āļ–āļ·āļ­āļŦāļļāđ‰āļ™
āļ›āļĢāļ°āđ€āļ āļ—āļœāļđāđ‰āļ–āļ·āļ­āļŦāļļāđ‰āļ™
āļœāļđāđ‰āļ–āļ·āļ­āļŦāļļāđ‰āļ™
āļœāļđāđ‰āļ–āļ·āļ­āļŦāļļāđ‰āļ™
āļŠāļąāļ”āļŠāđˆāļ§āļ™
BlackRock Institutional Trust Company, N.A.
12.96%
T. Rowe Price Associates, Inc.
12.75%
The Vanguard Group, Inc.
10.13%
Ortenzio (Robert A)
8.02%
Dimensional Fund Advisors, L.P.
4.20%
āļ­āļ·āđˆāļ™ āđ†
51.93%
āļœāļđāđ‰āļ–āļ·āļ­āļŦāļļāđ‰āļ™
āļœāļđāđ‰āļ–āļ·āļ­āļŦāļļāđ‰āļ™
āļŠāļąāļ”āļŠāđˆāļ§āļ™
BlackRock Institutional Trust Company, N.A.
12.96%
T. Rowe Price Associates, Inc.
12.75%
The Vanguard Group, Inc.
10.13%
Ortenzio (Robert A)
8.02%
Dimensional Fund Advisors, L.P.
4.20%
āļ­āļ·āđˆāļ™ āđ†
51.93%
āļ›āļĢāļ°āđ€āļ āļ—āļœāļđāđ‰āļ–āļ·āļ­āļŦāļļāđ‰āļ™
āļœāļđāđ‰āļ–āļ·āļ­āļŦāļļāđ‰āļ™
āļŠāļąāļ”āļŠāđˆāļ§āļ™
Investment Advisor
52.57%
Investment Advisor/Hedge Fund
18.21%
Individual Investor
16.10%
Hedge Fund
7.29%
Research Firm
2.78%
Pension Fund
1.25%
Bank and Trust
0.54%
Sovereign Wealth Fund
0.19%
Insurance Company
0.03%
āļ­āļ·āđˆāļ™ āđ†
1.04%

āļāļēāļĢāļ–āļ·āļ­āļŦāļļāđ‰āļ™āļ‚āļ­āļ‡āļŠāļ–āļēāļšāļąāļ™


āļ­āļąāļ›āđ€āļ”āļ•āđ€āļĄāļ·āđˆāļ­: āļ§āļąāļ™āļžāļļāļ˜āļ—āļĩāđˆ 1 āļ•.āļ„.
āļ­āļąāļ›āđ€āļ”āļ•āđ€āļĄāļ·āđˆāļ­: āļ§āļąāļ™āļžāļļāļ˜āļ—āļĩāđˆ 1 āļ•.āļ„.
āļŠāđˆāļ§āļ‡āđ€āļ§āļĨāļēāļāļēāļĢāļĢāļēāļĒāļ‡āļēāļ™
āļˆāļģāļ™āļ§āļ™āļŠāļ–āļēāļšāļąāļ™
āļŦāļļāđ‰āļ™āļ—āļĩāđˆāļ–āļ·āļ­āļ„āļĢāļ­āļ‡
āļŠāļąāļ”āļŠāđˆāļ§āļ™
āđ€āļ›āļĨāļĩāđˆāļĒāļ™
2025Q3
584
101.41M
81.89%
-13.28M
2025Q2
593
128.59M
103.28%
-15.30M
2025Q1
613
130.41M
101.46%
-13.79M
2024Q4
596
127.65M
98.98%
-7.70M
2024Q3
574
125.33M
96.47%
-2.82M
2024Q2
559
125.84M
96.80%
-1.37M
2024Q1
555
124.62M
97.09%
-1.67M
2023Q4
554
125.18M
97.72%
-2.54M
2023Q3
563
124.92M
98.22%
-6.02M
2023Q2
572
126.44M
99.43%
-8.51M
āļ”āļđāđ€āļžāļīāđˆāļĄāđ€āļ•āļīāļĄ

āļāļīāļˆāļāļĢāļĢāļĄāļœāļđāđ‰āļ–āļ·āļ­āļŦāļļāđ‰āļ™


āļŠāļ·āđˆāļ­
āļŦāļļāđ‰āļ™āļ—āļĩāđˆāļ–āļ·āļ­āļ„āļĢāļ­āļ‡
āļŠāļąāļ”āļŠāđˆāļ§āļ™
āđ€āļ›āļĨāļĩāđˆāļĒāļ™
āđ€āļ›āļĨāļĩāđˆāļĒāļ™%
āļ§āļąāļ™āļ—āļĩāđˆ
BlackRock Institutional Trust Company, N.A.
15.99M
12.9%
-497.15K
-3.01%
Jun 30, 2025
T. Rowe Price Associates, Inc.
16.02M
12.92%
-1.05M
-6.17%
Jun 30, 2025
The Vanguard Group, Inc.
12.90M
10.4%
-377.96K
-2.85%
Jun 30, 2025
Ortenzio (Robert A)
9.20M
7.42%
+250.00K
+2.79%
Jul 29, 2025
Dimensional Fund Advisors, L.P.
4.99M
4.02%
+773.73K
+18.35%
Jun 30, 2025
State Street Investment Management (US)
4.25M
3.43%
+55.69K
+1.33%
Jun 30, 2025
Rocco A. Ortenzio UEO
4.09M
3.3%
-3.80M
-48.22%
Dec 31, 2024
Geode Capital Management, L.L.C.
3.04M
2.45%
+80.42K
+2.72%
Jun 30, 2025
T. Rowe Price Investment Management, Inc.
3.60M
2.9%
-429.17K
-10.65%
Jun 30, 2025
Principal Global Investors (Equity)
2.92M
2.36%
+447.99K
+18.09%
Jun 30, 2025
āļ”āļđāđ€āļžāļīāđˆāļĄāđ€āļ•āļīāļĄ

ETF āļ—āļĩāđˆāđ€āļāļĩāđˆāļĒāļ§āļ‚āđ‰āļ­āļ‡


āļ­āļąāļ›āđ€āļ”āļ•āđ€āļĄāļ·āđˆāļ­: āļ§āļąāļ™āđ€āļŠāļēāļĢāđŒāļ—āļĩāđˆ 6 āļ˜.āļ„.
āļ­āļąāļ›āđ€āļ”āļ•āđ€āļĄāļ·āđˆāļ­: āļ§āļąāļ™āđ€āļŠāļēāļĢāđŒāļ—āļĩāđˆ 6 āļ˜.āļ„.
āļŠāļ·āđˆāļ­
āļŠāļąāļ”āļŠāđˆāļ§āļ™
State Street SPDR S&P Health Care Services ETF
2.26%
Invesco S&P SmallCap Value with Momentum ETF
0.98%
Invesco S&P SmallCap Health Care ETF
0.94%
Invesco S&P SmallCap High Dividend Low Volatility ETF
0.77%
First Trust Small Cap Value AlphaDEX Fund
0.71%
WisdomTree US SmallCap Quality Dividend Growth
0.71%
Invesco S&P SmallCap 600 Pure Value ETF
0.66%
Invesco S&P SmallCap 600 Revenue ETF
0.52%
Invesco Zacks Multi-Asset Income ETF
0.42%
Invesco S&P SmallCap Quality ETF
0.42%
āļ”āļđāđ€āļžāļīāđˆāļĄāđ€āļ•āļīāļĄ
State Street SPDR S&P Health Care Services ETF
āļŠāļąāļ”āļŠāđˆāļ§āļ™2.26%
Invesco S&P SmallCap Value with Momentum ETF
āļŠāļąāļ”āļŠāđˆāļ§āļ™0.98%
Invesco S&P SmallCap Health Care ETF
āļŠāļąāļ”āļŠāđˆāļ§āļ™0.94%
Invesco S&P SmallCap High Dividend Low Volatility ETF
āļŠāļąāļ”āļŠāđˆāļ§āļ™0.77%
First Trust Small Cap Value AlphaDEX Fund
āļŠāļąāļ”āļŠāđˆāļ§āļ™0.71%
WisdomTree US SmallCap Quality Dividend Growth
āļŠāļąāļ”āļŠāđˆāļ§āļ™0.71%
Invesco S&P SmallCap 600 Pure Value ETF
āļŠāļąāļ”āļŠāđˆāļ§āļ™0.66%
Invesco S&P SmallCap 600 Revenue ETF
āļŠāļąāļ”āļŠāđˆāļ§āļ™0.52%
Invesco Zacks Multi-Asset Income ETF
āļŠāļąāļ”āļŠāđˆāļ§āļ™0.42%
Invesco S&P SmallCap Quality ETF
āļŠāļąāļ”āļŠāđˆāļ§āļ™0.42%

āđ€āļ‡āļīāļ™āļ›āļąāļ™āļœāļĨ


āļĄāļĩāļāļēāļĢāļˆāđˆāļēāļĒāđ€āļ‡āļīāļ™āļ›āļąāļ™āļœāļĨāđ€āļ›āđ‡āļ™āļˆāļģāļ™āļ§āļ™āļĢāļ§āļĄ 243.71M USD āđƒāļ™āļŠāđˆāļ§āļ‡ 5 āļ›āļĩāļ—āļĩāđˆāļœāđˆāļēāļ™āļĄāļē
āļ§āļąāļ™āļ—āļĩāđˆ
āđ€āļ‡āļīāļ™āļ›āļąāļ™āļœāļĨ
āļ§āļąāļ™āļ—āļĩāđˆāļšāļąāļ™āļ—āļķāļ
āļ§āļąāļ™āļ—āļĩāđˆāļŠāļģāļĢāļ°āđ€āļ‡āļīāļ™
āļ§āļąāļ™āļ—āļĩāđˆāđ„āļĄāđˆāđ„āļ”āđ‰āļĢāļąāļšāļŠāļīāļ—āļ˜āļīāļ›āļąāļ™āļœāļĨ
Oct 30, 2025
SEM.NB Final Cash Dividend of gross USD 0.0625 paid on Nov 25, 2025 going ex on Nov 12, 2025
Nov 12, 2025
Nov 25, 2025
Nov 12, 2025
Jul 31, 2025
SEM.NB Interim Cash Dividend of gross USD 0.0625 paid on Aug 28, 2025 going ex on Aug 13, 2025
Aug 13, 2025
Aug 28, 2025
Aug 13, 2025
May 01, 2025
SEM.NB Interim Cash Dividend of gross USD 0.0625 paid on May 29, 2025 going ex on May 15, 2025
May 15, 2025
May 29, 2025
May 15, 2025
Feb 20, 2025
SEM.NB Interim Cash Dividend of gross USD 0.0625 paid on Mar 13, 2025 going ex on Mar 03, 2025
Mar 03, 2025
Mar 13, 2025
Mar 03, 2025
Oct 31, 2024
SEM.NB Final Cash Dividend of gross USD 0.125 paid on Nov 26, 2024 going ex on Nov 13, 2024
Nov 13, 2024
Nov 26, 2024
Nov 13, 2024
Aug 01, 2024
SEM.NB Interim Cash Dividend of gross USD 0.125 paid on Aug 30, 2024 going ex on Aug 14, 2024
Aug 14, 2024
Aug 30, 2024
Aug 14, 2024
May 02, 2024
SEM.NB Interim Cash Dividend of gross USD 0.125 paid on May 30, 2024 going ex on May 15, 2024
May 16, 2024
May 30, 2024
May 15, 2024
Feb 22, 2024
SEM.NB Interim Cash Dividend of gross USD 0.125 paid on Mar 13, 2024 going ex on Feb 29, 2024
Mar 01, 2024
Mar 13, 2024
Feb 29, 2024
Nov 02, 2023
SEM.NB Final Cash Dividend of gross USD 0.125 paid on Nov 28, 2023 going ex on Nov 14, 2023
Nov 15, 2023
Nov 28, 2023
Nov 14, 2023
Aug 03, 2023
SEM.NB Interim Cash Dividend of gross USD 0.125 paid on Sep 01, 2023 going ex on Aug 14, 2023
Aug 15, 2023
Sep 01, 2023
Aug 14, 2023
āļ”āļđāđ€āļžāļīāđˆāļĄāđ€āļ•āļīāļĄ

āļāļēāļĢāđāļšāđˆāļ‡āļŦāļļāđ‰āļ™


āļ§āļąāļ™āļ—āļĩāđˆ
āļ›āļĢāļ°āđ€āļ āļ—
āļ­āļąāļ•āļĢāļēāļŠāđˆāļ§āļ™
āđ„āļĄāđˆāļĄāļĩāļ‚āđ‰āļ­āļĄāļđāļĨ
āļ§āļąāļ™āļ—āļĩāđˆ
āļ›āļĢāļ°āđ€āļ āļ—
āļ­āļąāļ•āļĢāļēāļŠāđˆāļ§āļ™
āđ„āļĄāđˆāļĄāļĩāļ‚āđ‰āļ­āļĄāļđāļĨ

āļ„āļģāļ–āļēāļĄāļ—āļĩāđˆāļžāļšāļšāđˆāļ­āļĒ

āđƒāļ„āļĢāļ„āļ·āļ­āļœāļđāđ‰āļ–āļ·āļ­āļŦāļļāđ‰āļ™āļŦāđ‰āļēāļ­āļąāļ™āļ”āļąāļšāđāļĢāļāļ‚āļ­āļ‡ Select Medical Holdings Corp?


āļœāļđāđ‰āļ–āļ·āļ­āļŦāļļāđ‰āļ™āļŦāđ‰āļēāļ­āļąāļ™āļ”āļąāļšāđāļĢāļāļ‚āļ­āļ‡ Select Medical Holdings Corp āđ„āļ”āđ‰āđāļāđˆ:
BlackRock Institutional Trust Company, N.A. āļ–āļ·āļ­āļ„āļĢāļ­āļ‡āļŦāļļāđ‰āļ™āļˆāļģāļ™āļ§āļ™ 15.99M āļŦāļļāđ‰āļ™ āļ„āļīāļ”āđ€āļ›āđ‡āļ™ 12.90% āļ‚āļ­āļ‡āļŦāļļāđ‰āļ™āļ—āļąāđ‰āļ‡āļŦāļĄāļ”
T. Rowe Price Associates, Inc. āļ–āļ·āļ­āļ„āļĢāļ­āļ‡āļŦāļļāđ‰āļ™āļˆāļģāļ™āļ§āļ™ 16.02M āļŦāļļāđ‰āļ™ āļ„āļīāļ”āđ€āļ›āđ‡āļ™ 12.92% āļ‚āļ­āļ‡āļŦāļļāđ‰āļ™āļ—āļąāđ‰āļ‡āļŦāļĄāļ”
The Vanguard Group, Inc. āļ–āļ·āļ­āļ„āļĢāļ­āļ‡āļŦāļļāđ‰āļ™āļˆāļģāļ™āļ§āļ™ 12.90M āļŦāļļāđ‰āļ™ āļ„āļīāļ”āđ€āļ›āđ‡āļ™ 10.40% āļ‚āļ­āļ‡āļŦāļļāđ‰āļ™āļ—āļąāđ‰āļ‡āļŦāļĄāļ”
Ortenzio (Robert A) āļ–āļ·āļ­āļ„āļĢāļ­āļ‡āļŦāļļāđ‰āļ™āļˆāļģāļ™āļ§āļ™ 9.20M āļŦāļļāđ‰āļ™ āļ„āļīāļ”āđ€āļ›āđ‡āļ™ 7.42% āļ‚āļ­āļ‡āļŦāļļāđ‰āļ™āļ—āļąāđ‰āļ‡āļŦāļĄāļ”
Dimensional Fund Advisors, L.P. āļ–āļ·āļ­āļ„āļĢāļ­āļ‡āļŦāļļāđ‰āļ™āļˆāļģāļ™āļ§āļ™ 4.99M āļŦāļļāđ‰āļ™ āļ„āļīāļ”āđ€āļ›āđ‡āļ™ 4.02% āļ‚āļ­āļ‡āļŦāļļāđ‰āļ™āļ—āļąāđ‰āļ‡āļŦāļĄāļ”

āļ›āļĢāļ°āđ€āļ āļ—āļœāļđāđ‰āļ–āļ·āļ­āļŦāļļāđ‰āļ™āļŠāļēāļĄāļ­āļąāļ™āļ”āļąāļšāđāļĢāļāļ‚āļ­āļ‡ Select Medical Holdings Corp āļ„āļ·āļ­āļ­āļ°āđ„āļĢ?


āļ›āļĢāļ°āđ€āļ āļ—āļœāļđāđ‰āļ–āļ·āļ­āļŦāļļāđ‰āļ™āļŠāļēāļĄāļ­āļąāļ™āļ”āļąāļšāđāļĢāļāļ‚āļ­āļ‡ Select Medical Holdings Corp āđ„āļ”āđ‰āđāļāđˆ
BlackRock Institutional Trust Company, N.A.
T. Rowe Price Associates, Inc.
The Vanguard Group, Inc.

āļĄāļĩāļāļĩāđˆāļŠāļ–āļēāļšāļąāļ™āļ—āļĩāđˆāļ–āļ·āļ­āļŦāļļāđ‰āļ™āļ‚āļ­āļ‡ Select Medical Holdings Corp (SEM)?


āļ“ āļ§āļąāļ™āļ—āļĩāđˆ 2025Q3 āļĄāļĩāļŠāļ–āļēāļšāļąāļ™āļˆāļģāļ™āļ§āļ™ 584 āđāļŦāđˆāļ‡āļ—āļĩāđˆāļ–āļ·āļ­āļŦāļļāđ‰āļ™āļ‚āļ­āļ‡ Select Medical Holdings Corp āđ‚āļ”āļĒāļĄāļĩāļĄāļđāļĨāļ„āđˆāļēāļĢāļ§āļĄāļ›āļĢāļ°āļĄāļēāļ“ 101.41M āļ„āļīāļ”āđ€āļ›āđ‡āļ™ 81.89% āļ‚āļ­āļ‡āļŦāļļāđ‰āļ™āļ—āļąāđ‰āļ‡āļŦāļĄāļ” āđ€āļĄāļ·āđˆāļ­āđ€āļ—āļĩāļĒāļšāļāļąāļšāļ§āļąāļ™āļ—āļĩāđˆ 2025Q2 āļāļēāļĢāļ–āļ·āļ­āļŦāļļāđ‰āļ™āļ‚āļ­āļ‡āļŠāļ–āļēāļšāļąāļ™āđ„āļ”āđ‰āđ€āļžāļīāđˆāļĄāļ‚āļķāđ‰āļ™ -21.39%

āđāļŦāļĨāđˆāļ‡āļĢāļēāļĒāđ„āļ”āđ‰āļŦāļĨāļąāļāļ‚āļ­āļ‡ Select Medical Holdings Corp āļ„āļ·āļ­āļ­āļ°āđ„āļĢ?


āđ€āļĄāļ·āđˆāļ­āļ§āļąāļ™āļ—āļĩāđˆ FY2025Q2 āļ˜āļļāļĢāļāļīāļˆāļ”āđ‰āļēāļ™ Non-Medicar āļŠāļĢāđ‰āļēāļ‡āļĢāļēāļĒāđ„āļ”āđ‰āļŠāļđāļ‡āļŠāļļāļ”āđƒāļŦāđ‰āļāļąāļš Select Medical Holdings Corp āļ„āļīāļ”āđ€āļ›āđ‡āļ™āļĄāļđāļĨāļ„āđˆāļē 826.30M āđāļĨāļ°āļ„āļīāļ”āđ€āļ›āđ‡āļ™ 61.68% āļ‚āļ­āļ‡āļĢāļēāļĒāđ„āļ”āđ‰āļĢāļ§āļĄ
KeyAI
î™